433 related articles for article (PubMed ID: 32346964)
1. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases.
Nguyen LD; Ehrlich BE
EMBO Mol Med; 2020 Jun; 12(6):e12075. PubMed ID: 32346964
[TBL] [Abstract][Full Text] [Related]
2. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
[TBL] [Abstract][Full Text] [Related]
3. Chemobrain: An accelerated aging process linking adenosine A
Oliveros A; Poleschuk M; Cole PD; Boison D; Jang MH
Int Rev Neurobiol; 2023; 170():267-305. PubMed ID: 37741694
[TBL] [Abstract][Full Text] [Related]
4. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
[TBL] [Abstract][Full Text] [Related]
5. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Sahu K; Singh S; Devi B; Singh C; Singh A
Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
[TBL] [Abstract][Full Text] [Related]
6. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
[No Abstract] [Full Text] [Related]
7. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
8. Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward.
Raghu SV; Kudva AK; Rao S; Prasad K; Mudgal J; Baliga MS
Food Funct; 2021 Nov; 12(22):11132-11153. PubMed ID: 34704580
[TBL] [Abstract][Full Text] [Related]
9. Senolytic treatment alleviates doxorubicin-induced chemobrain.
Budamagunta V; Kumar A; Rani A; Manohar Sindhu S; Yang Y; Zhou D; Foster TC
Aging Cell; 2024 Feb; 23(2):e14037. PubMed ID: 38225896
[TBL] [Abstract][Full Text] [Related]
10. Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks.
Wahdan SA; El-Derany MO; Abdel-Maged AE; Azab SS
Neurochem Int; 2020 Sep; 138():104777. PubMed ID: 32479984
[TBL] [Abstract][Full Text] [Related]
11. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.
Wang XM; Walitt B; Saligan L; Tiwari AF; Cheung CW; Zhang ZJ
Cytokine; 2015 Mar; 72(1):86-96. PubMed ID: 25573802
[TBL] [Abstract][Full Text] [Related]
12. [Chemobrain].
Szentmartoni G; Makkos Z; Dank M
Neuropsychopharmacol Hung; 2018 Sep; 20(3):112-116. PubMed ID: 30459288
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
Alhowail AH; Aldubayan M
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
[TBL] [Abstract][Full Text] [Related]
14. "Chemobrain" in childhood cancer survivors-the impact on social, academic, and daily living skills: a qualitative systematic review.
Semendric I; Pollock D; Haller OJ; George RP; Collins-Praino LE; Whittaker AL
Support Care Cancer; 2023 Aug; 31(9):532. PubMed ID: 37606711
[TBL] [Abstract][Full Text] [Related]
15. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
[TBL] [Abstract][Full Text] [Related]
16. "Emotional Chemobrain": A new concept for chemotherapy adverse drug effect?
Bou Khalil R
Encephale; 2021 Dec; 47(6):613-615. PubMed ID: 33190820
[TBL] [Abstract][Full Text] [Related]
17. Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
Tong Y; Wang K; Sheng S; Cui J
Biosci Biotechnol Biochem; 2020 Jun; 84(6):1201-1210. PubMed ID: 31992173
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
19. Modulation of mitochondrial dynamics rescues cognitive function in rats with 'doxorubicin-induced chemobrain' via mitigation of mitochondrial dysfunction and neuroinflammation.
Ongnok B; Maneechote C; Chunchai T; Pantiya P; Arunsak B; Nawara W; Chattipakorn N; Chattipakorn SC
FEBS J; 2022 Oct; 289(20):6435-6455. PubMed ID: 35514149
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.
El-Agamy SE; Abdel-Aziz AK; Esmat A; Azab SS
Cancer Chemother Pharmacol; 2019 Jul; 84(1):1-14. PubMed ID: 30955080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
